Skip to main content

Table 1 Patient characteristics of the test and re-test groups

From: Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients

  Baseline (T0, pre-operatively) 3 months (T3, post-operatively) Test-retest (T3 retest)a
Population size (n) 260 182 62
Age (years)
 Mean ± SD 67 ± 10 67 ± 9 67 ± 8
 Median (min-max) 68 (35–88) 68 (38–82) 67 (40–82)
Gender, n (%)
 Women 53 (20%) 37 (20%) 14 (23%)
 Men 207 (80%) 145 (80%) 48 (77%)
Type of surgery, n (%)
 RARC 142 (55%) 99 (54%) 32 (52%)
 ORC 112 (43%) 78 (43%) 30 (48%)
 LRC 6 (2%) 5 (3%) 0 (0%)
Diversion type, n (%)
 Own bladder 233 (90%) 0 (0%) 0 (0%)
 Ileal conduit 11 (4%) 114 (63%) 45 (72%)
 Neobladder 1 (0%) 33 (18%) 11 (18%)
 Other 3 (1%) 31 (17%) 6 (10%)
 Missing 12 (5%) 4 (2%) 0 (0%)
Preoperative chemotherapy (yes), n (%) 38 (15%) 28 (15%) 8 (13%)
Education, n (%)
 Elementary school or less 22 (8%) 17 (9%) 3 (5%)
 Secondary education 94 (36%) 67 (37%) 20 (32%)
 Postsecondary education 116 (45%) 87 (48%) 36 (58%)
 Missing 28 (11%) 11 (6%) 3 (5%)
Living status, n (%)
 Married 177 (68%) 136 (75%) 51 (82%)
 Other 83 (32%) 46 (25%) 11 (18%)
Employment status, n (%)
 Pension 149 (57%) 108 (59%) 36 (58%)
 Salaried employment 61 (24%) 44 (25%) 19 (31%)
 Other 23 (9%) 19 (10%) 4 (6%)
 Missing 27 (10%) 11 (6%) 3 (5%)
  1. aTwo weeks after T3. RARC robot-assisted radical cystectomy, ORC open radical cystectomy, LRC laparoscopic-assisted radical cystectomy
\